Inspira Technologies OXY B.H.N. Ltd., a groundbreaking life support technology company, announced that it has entered into an agreement with Glo-Med Networks Inc (Glo-Med), which will serve as Inspira ...
Jubilant Therapeutics Inc., has announced the dosing of first patients in global clinical trials involving two pipeline programs: phase I/II clinical trial of JBI-802 in heme-oncology and phase I ...